The following outstanding potentially dilutive shares have been excluded from the calculation of diluted net loss per share for the period presented due to their anti-dilutive effect:


	March 31,
	2026	2025
Stock options to purchase common stock	37,916,047	31,532,800
Restricted stock units outstanding (Excluding vested but unreleased shares, which are included in weighted-average common shares outstanding)	15,720,910	18,079,422
Expected shares to be purchased under Employee Stock Purchase Plan	1,409,334	1,809,262
Total	55,046,291	51,421,484